PRECIGEN, INC. — Director's Dealing 2017

Dec 7, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2017-11-27

Reporting Person: Walsh Robert F. III (SVP, Methanotroph & Fine Chem.)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock (Right to Buy)	$9.30	2023-05-28	Common Stock (118772)		Direct
Option to Purchase Common Stock (Right to Buy)	$29.56	2024-03-20	Common Stock (103926)		Direct
Option to Purchase Common Stock (Right to Buy)	$20.94	2027-02-02	Common Stock (225000)		Direct

Footnotes

F1: This option vests in 25% increments on each of March 20, 2015, 2016, 2017, and 2018.

F2: This option vests in 25% increments on each of February 2, 2018, 2019, 2020, and 2021.